These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12707028)

  • 41. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells.
    Cuevas P; Díaz-González D; Sánchez I; Lozano RM; Giménez-Gallego G; Dujovny M
    Neurol Res; 2006 Mar; 28(2):127-30. PubMed ID: 16551428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck.
    Arany I; Chen SH; Megyesi JK; Adler-Storthz K; Chen Z; Rajaraman S; Ember IA; Tyring SK; Brysk MM
    Cancer Lett; 2003 Sep; 199(1):83-9. PubMed ID: 12963127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway.
    Puthier D; Bataille R; Amiot M
    Eur J Immunol; 1999 Dec; 29(12):3945-50. PubMed ID: 10602002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
    Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
    Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-Formylchromone inhibits proliferation and induces apoptosis of multiple myeloma cells by abrogating STAT3 signaling through the induction of PIAS3.
    Ko JH; Ho Baek S; Nam D; Chung WS; Lee SG; Lee J; Mo Yang W; Um JY; Seok Ahn K
    Immunopharmacol Immunotoxicol; 2016 Oct; 38(5):334-43. PubMed ID: 27324722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IGF-1 stimulated upregulation of cyclin D1 is mediated via STAT5 signaling pathway in neuronal cells.
    Kalita A; Gupta S; Singh P; Surolia A; Banerjee K
    IUBMB Life; 2013 May; 65(5):462-71. PubMed ID: 23504816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
    Catlett-Falcone R; Landowski TH; Oshiro MM; Turkson J; Levitzki A; Savino R; Ciliberto G; Moscinski L; Fernández-Luna JL; Nuñez G; Dalton WS; Jove R
    Immunity; 1999 Jan; 10(1):105-15. PubMed ID: 10023775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Involvement of cyclin D1 and E2F1 in intramedullary apoptosis in myelodysplastic syndromes.
    Saberwal G; Broderick E; Janssen I; Shetty V; Alvi S; Lisak L; Venugopal P; Raza A; Mundle SD
    J Hematother Stem Cell Res; 2003 Aug; 12(4):443-50. PubMed ID: 12965081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
    Kannaiyan R; Hay HS; Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Chng WJ; Sethi G
    Br J Pharmacol; 2011 Nov; 164(5):1506-21. PubMed ID: 21506956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin D1 sensitizes myeloma cells to endoplasmic reticulum stress-mediated apoptosis by activating the unfolded protein response pathway.
    Bustany S; Cahu J; Guardiola P; Sola B
    BMC Cancer; 2015 Apr; 15():262. PubMed ID: 25881299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
    Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
    Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclin D1 expression in patients with multiple myeloma.
    Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B
    Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclin D1 amplification in multiple myeloma is associated with multidrug resistance expression.
    Sewify EM; Afifi OA; Mosad E; Zaki AH; El Gammal SA
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):215-22. PubMed ID: 24468132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency and prognostic relevance of cyclin D1 dysregulation in multiple myeloma.
    Rasmussen T; Knudsen LM; Johnsen HE
    Eur J Haematol; 2001; 67(5-6):296-301. PubMed ID: 11872077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma.
    Ma XT; Wang S; Ye YJ; Du RY; Cui ZR; Somsouk M
    World J Gastroenterol; 2004 Jun; 10(11):1569-73. PubMed ID: 15162527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.
    Aoki Y; Feldman GM; Tosato G
    Blood; 2003 Feb; 101(4):1535-42. PubMed ID: 12393476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.
    Yata K; Sadahira Y; Otsuki T; Sakaguchi H; Isozaki Y; Uno M; Kurebayashi J; Fujii T; Eda S; Ueki A; Yawata Y; Yamada O; Sugihara T
    Br J Haematol; 2001 Sep; 114(3):591-9. PubMed ID: 11552984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
    Toyonaga T; Nakano K; Nagano M; Zhao G; Yamaguchi K; Kuroki S; Eguchi T; Chijiiwa K; Tsuneyoshi M; Tanaka M
    Cancer Lett; 2003 Nov; 201(1):107-16. PubMed ID: 14580692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.
    Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL
    Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.